Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, 5020 Salzburg, Austria.
Department of Biosciences, Paris Lodron University of Salzburg, 5020 Salzburg, Austria.
Int J Mol Sci. 2022 Jan 20;23(3):1094. doi: 10.3390/ijms23031094.
Chronic lymphocytic leukemia (CLL) is a very common and mostly incurable B-cell malignancy. Recent studies revealed high interpatient mutational heterogeneity and worsened therapy response and survival of patients with complex genomic aberrations. In line with this, a better understanding of the underlying mechanisms of specific genetic aberrations would reveal new prognostic factors and possible therapeutic targets. It is known that chromosomal rearrangements including DNA insertions often play a role during carcinogenesis. Recently it was reported that bacteria (microbiome)-human lateral gene transfer occurs in somatic cells and is enriched in cancer samples. To further investigate this mechanism in CLL, we analyzed paired-end RNA sequencing data of 45 CLL patients and 9 healthy donors, in which we particularly searched for bacterial DNA integrations into the human somatic genome. Applying the Burrows-Wheeler aligner (BWA) first on a human genome and then on bacterial genome references, we differentiated between sequencing reads mapping to the human genome, to the microbiome or to bacterial integrations into the human genome. Our results indicate that CLL samples featured bacterial DNA integrations more frequently (approx. two-fold) compared to normal samples, which corroborates the latest findings in other cancer entities. Moreover, we determined common integration sites and recurrent integrated bacterial transcripts. Finally, we investigated the contribution of bacterial integrations to oncogenesis and disease progression.
慢性淋巴细胞白血病(CLL)是一种非常常见且大多无法治愈的 B 细胞恶性肿瘤。最近的研究表明,复杂基因组异常的患者存在较高的个体间突变异质性,导致治疗反应和生存情况恶化。与此一致的是,更好地了解特定遗传异常的潜在机制将揭示新的预后因素和可能的治疗靶点。已知包括 DNA 插入在内的染色体重排通常在致癌过程中起作用。最近有报道称,细菌(微生物组)-人类横向基因转移发生在体细胞中,并在癌症样本中富集。为了进一步研究 CLL 中的这种机制,我们分析了 45 名 CLL 患者和 9 名健康供体的配对端 RNA 测序数据,其中我们特别搜索了细菌 DNA 整合到人类体细胞基因组中的情况。我们首先应用 Burrows-Wheeler 比对器(BWA)对人类基因组进行比对,然后对细菌基因组进行比对,从而区分映射到人类基因组、微生物组或细菌整合到人类基因组的测序reads。我们的结果表明,与正常样本相比,CLL 样本中更频繁地出现细菌 DNA 整合(约两倍),这与其他癌症实体的最新发现一致。此外,我们确定了常见的整合位点和反复整合的细菌转录本。最后,我们研究了细菌整合对肿瘤发生和疾病进展的贡献。